About the study

This study is a regulatory postmarketing surveillance study for Empliciti with a representative sample of the overall Korean multiple myeloma (MM) population.

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria

1. Adult participants who have a confirmed diagnosis of Multiple Myeloma (MM)

Exclusion criteria

1. Participants who use Empliciti for therapeutic indications which are not approved for Empliciti combination therapy in Korea
2. Patients in whom treatment with Empliciti (as clarified in the Korean label) is contraindicated Other protocol defined inclusion/exclusion criteria could apply

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.